InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001438133-23-000020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-17 2023-02-15 TNDM Morrison Susan EVP, Chief Admin. Off F - Tax $43.11 -55 10.6K -0.5% -$2,371
D 2023-02-17 2023-02-15 TNDM Morrison Susan EVP, Chief Admin. Off M - OptEx $0.00 +162 10.6K +2% $0
D 2023-02-17 2023-02-15 TNDM Morrison Susan EVP, Chief Admin. Off M - OptEx $0.00 +162 1,462 +12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-15 F D 55 $43.11 10,582 D — —
2 Common Common Stock 2023-02-15 M A 162 $0.00 10,637 D — —
3 Derivative Restricted Stock Unit 2023-02-15 M A 162 $0.00 1,462 D — · — to — 162 Common Stock (F2) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). (F3) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. (F4) RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan.